Lipocine
LPCN
LPCN
19 hedge funds and large institutions have $1.35M invested in Lipocine in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
10% less funds holding
Funds holding: 21 → 19 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
19
Holding in Top 10
–
Calls
$397K
Puts
$1K
Top Buyers
| 1 | +$86.3K | |
| 2 | +$8.85K | |
| 3 | +$5.54K | |
| 4 |
Morgan Stanley
New York
|
+$2.01K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$85 |
Top Sellers
| 1 | -$85.7K | |
| 2 | -$49.8K | |
| 3 | -$11.5K | |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$2K |
| 5 |
JPMorgan Chase & Co
New York
|
-$483 |